Global Breast Biopsy Devices Market Size & Trends Report Segmented by Product (Biopsy Needles, Guidance Systems, Biopsy Tables), Application (Early Screening, Therapy Selection, Treatment Monitoring), End-user Analysis & Regional Forecast to 2030
The global breast biopsy devices market is expected to grow at a CAGR of ~6% during the forecast period. Increase in the incidence of breast cancer, technological advancements in the image-guided techniques, expansion of breast cancer screening programs, and growing preference for minimally invasive techniques are some of the key driving factors supporting market growth. To learn more about the research report, download a sample report.
Overview
Breast biopsy devices are specialized tools designed to help clinicians accurately identify and diagnose abnormalities in breast tissue, particularly when early signs of cancer are suspected. There are several types of breast biopsy techniques, each requiring specific devices.
- Core Needle Biopsy (CNB): Uses a hollow needle to remove tissue samples, typically guided by imaging technologies such as ultrasound, mammography (stereotactic biopsy), or MRI
- Vacuum-Assisted Biopsy (VAB): Utilizes suction to extract multiple tissue samples through a single needle insertion, offering higher accuracy with fewer complications
- Fine Needle Aspiration (FNA): Involves a thin needle to collect fluid or cells, commonly used for cysts or small nodules
- Surgical Biopsy: A more invasive procedure where part or all of a suspicious mass is surgically removed for examination
These imaging techniques support precise targeting of suspicious areas, making the procedure safer and more comfortable for patients while reducing the need for surgical intervention.

To learn more about this report, download the PDF brochure
AI and imaging innovation are transforming accuracy in breast biopsy devices
Rapid advancements in image-guided techniques have transformed breast biopsy procedures by making them less invasive and more accurate. The integration of imaging modalities such as ultrasound, magnetic resonance imaging (MRI), and stereotactic mammography allows clinicians to precisely localize suspicious lesions within breast tissue, thereby facilitating accurate needle placement during biopsy. This precision facilitates the early detection of malignancies and significantly reduces the likelihood of false negatives.
Recent developments in imaging systems and the compatibility of biopsy devices with various imaging platforms have also contributed to a more patient-friendly and efficient diagnostic experience. The use of smaller, more refined instruments enables efficient tissue sampling with minimal discomfort and eliminates the need for surgical intervention in many cases. Moreover, the incorporation of artificial intelligence (AI) into imaging workflows is transforming breast cancer detection and biopsy accuracy. According to the Breast Cancer Research Foundation (BCRF), AI algorithms can make diagnostic labs' workflow more efficient and minimize human bias, while AI-powered software can automate the interpretation of mammograms, ultrasounds, and MRI scans, allowing patients to receive results faster and with greater consistency. Furthermore, the improved visualization provided by advanced imaging reduces the incidence of repeat procedures, enhancing diagnostic efficiency. Collectively, these innovations have reinforced the clinical utility of image-guided biopsy techniques and promoted their integration into routine breast cancer diagnostic pathways.

To learn more about this report, download the PDF brochure
Growing adoption of ultrasound-guided biopsy accelerates market expansion
The widespread use of ultrasound-guided biopsy is gaining traction in the breast biopsy devices market, as this method is preferred for its lower invasiveness, accurate targeting of suspicious areas, and reduced need for repeat procedures. This method enables real-time imaging, thereby allowing clinicians to adjust the needle placement dynamically with improved diagnostic accuracy. Compared to other biopsy techniques, the ultrasound-guided procedure involves lower radiation exposure, which has made this diagnostic technology safer for younger patients and ideal for those undergoing routine screenings. Moreover, innovations in device design, such as vacuum-assisted and portable systems, have further improved the effectiveness and ease of use of these procedures, particularly in ambulatory and low-resource settings. With the expansion in breast cancer screening programs globally, ultrasound-guided biopsy is emerging as a vital component of modern breast diagnostics.
Competitive Landscape Analysis
The global breast biopsy devices market is marked by the presence of established and emerging market players such as Hologic Inc.; Danaher Corporation; Becton, Dickinson and Company; Argon Medical Devices, Inc.; Merit Medical Systems,Inc.; Fujifilm Corporation; Hoffman La-Roche Ltd.; QIAGEN; Cook Medical Inc.; and Devicor Medical Products Inc., among others.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | ~6% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product, Application, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Hologic Inc.; Danaher Corporation; Becton,Dickinson and Company; Argon Medical Devices,Inc.; Merit Medical Systems,Inc.; Fujifilm Corporation; Hoffman La-Roche Ltd.; QIAGEN; Cook Medical Inc.; Devicor Medical Products Inc.; among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Â
Global Breast Biopsy Devices Market Segmentation
This report by Medi-Tech Insights provides the size of the global breast biopsy devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, application, and end-user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Biopsy Needles
- Guidance Systems
- Biopsy Tables
- Liquid Biopsy Instruments
- Localization Wires
- Others
Market Size & Forecast (2023-2030), By Application, USD Million
- Early Screening
- Therapy Selection
- Treatment Monitoring
- Reoccurrence Monitoring
Market Size & Forecast (2023-2030), By End-user, USD Million
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the breast biopsy devices market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the breast biopsy devices market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction​
- Market Scope​
- Market Definition​
- Segments Covered​
- Regional Segmentation​
- Research Timeframe​
- Currency Considered​
- Study Limitations​
- Stakeholders​
- List of Abbreviations​
- Key Conferences and Events (2025-2026)​
- Research Methodology​
- Secondary Research​
- Primary Research​
- Market Estimation​
- Bottom-Up Approach​
- Top-Down Approach​
- Market Forecasting​
- Executive Summary
- Breast Biopsy Devices Market Snapshot (2025-2030)​
- Segment Overview​
- Regional Snapshot​
- Competitive Insights ​
- Market Overview
- Market Dynamics
- Drivers
- Increase in incidence of breast cancer
- Growing preference for minimally invasive techniques
- Technological advancement in image-guided techniques
- Expansion of breast cancer screening programs
- Growing healthcare investments and improved diagnostic infrastructure
- Restraints​
- High costs of advanced imaging & biopsy equipment
- Risk of false negatives or inconclusive results in small lesion detection
- Limited accessibility to image-guided systems in low-resource regions
- Opportunities​
- Growing demand for portable and handheld biopsy devices
- Increasing R&D for AI-driven biopsy navigation and automation tools
- Strategic collaborations and mergers enhancing product portfolios
- Key Market Trends​
- Development of hybrid imaging technologies integrating multiple modalities
- Integration of AI and machine learning for improved lesion detection
- Unmet Market Needs​
- Industry Speaks​
- Drivers
- Market Dynamics
- Global Breast Biopsy Devices Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction​
- Biopsy Needles
- Guidance Systems
- Biopsy Tables
- Liquid Biopsy Instruments
- Others
- Global Breast Biopsy Devices Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction​
- Early Screening
- Therapy Selection
- Treatment Monitoring
- Reoccurrence Monitoring
- Global Breast Biopsy Devices Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction​
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
- Global Breast Biopsy Devices Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction​
- North America Breast Biopsy Devices Market Size & Forecast (2023-2030), By Country, USD Million​
- US​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End-user (USD Million)
- Canada​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US​
- Europe Breast Biopsy Devices Market Size & Forecast (2023-2030), By Country, USD Million​
- UK ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)​
- Rest of Europe ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK ​
- Asia Pacific (APAC) Breast Biopsy Devices Market Size & Forecast (2023-2030), By Country, USD Million​
- China ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)​
- Japan ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)​
- Rest of Asia Pacific ​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China ​
- Latin America (LATAM) Breast Biopsy Devices Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Breast Biopsy Devices Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Product (USD Million)​
- Market Size & Forecast, By Application (USD Million)​
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Hologic Inc.
- Danaher Corporation
- Becton, Dickinson and Company
- Argon Medical Devices Inc.
- Merit Medical Systems Inc.
- Fujifilm Corporation
- Hoffman La-Roche Ltd.
- QIAGEN
- Cook Medical Inc.
- Devicor Medical Products Inc.
- Other Prominent Players
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)

Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
Breakdown of Primary Interviews

Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
Features of the Report
- Comprehensive Market Coverage
- Market Size and Forecast
- Geographic & Segment Deep Dives
- Strategic Insights & Competitive Landscape
- Timely & Updated Data
- Growth Indicators & Future Outlook
- Quick Turnaround on Queries
- Analyst Support
- Report Customization Available
- Reports in PDF & Excel


